Pembrolizumab monotherapy for high-risk, non-muscle invasive bladder cancer - Authors' reply
- Arjun V Balar 1, Ashish M Kamat 2, Ronald de Wit 3,
- Arjun V Balar 1, Ashish M Kamat 2, Ronald de Wit 3
- 1Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY 10016, USA.
- 2MD Anderson Cancer Center, University of Texas, Houston, TX, USA.
- 3Erasmus University Medical Center, Rotterdam, Netherlands.
- 0Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY 10016, USA.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

